Global Bridge Pharmaceutical (GB Pharma USA) is a U.S.-based, FDA-registered pharmaceutical company dedicated to expanding access to safe, high-quality medicines between the United States and Africa. The company serves as a strategic bridge connecting American pharmaceutical manufacturers, healthcare institutions, and supply partners with hospitals, clinics, governments, and private sector stakeholders across African markets.

GB Pharma specializes in global access programs designed to improve the availability of essential, specialty, and life-saving medicines in underserved regions. A core area of expertise includes the sourcing and export of hard-to-find, shortage, and specialty drugs from the United States to African healthcare providers, ensuring regulatory compliance, product integrity, and reliable supply chain coordination.

In addition to pharmaceutical export services, GB Pharma supports U.S. pharmaceutical and healthcare companies seeking responsible entry into African markets. The company provides market linkage, regulatory navigation support, institutional partnerships, and strategic advisory services to facilitate sustainable expansion and long-term collaboration.

Through its diaspora-focused initiatives, hospital partnerships, and government engagement efforts, Global Bridge Pharmaceutical is committed to strengthening healthcare systems, reducing medication gaps, and fostering ethical, transparent pharmaceutical trade between the U.S. and Africa.